Real Money’s Stephen ‘Sarge’ Guilfoyle sees longer term appreciation as EV business expands. The stock of Ford Motor Co. (F) – Get Ford Motor Company Report has the potential for more growth even after a stellar run Read more…
Temporary work company has been hard hit during covid. As regular readers will know, one of Paul Price’s most consistent strategies is to look for good companies hit by bad trading. These are the stocks Read more…
Fifty-eight percent of employees surveyed said they would search for a new job if they can’t continue working from home post-pandemic, FlexJobs says. The number of remote job listings jumped 12% in 2021, according to Read more…
IBM stock was whacked on Tuesday following an analyst downgrade. However, the decline highlighted two key levels on the chart. Forgotten by many, the charts for International Business Machines (IBM) – Get International Business Machines Read more…
Real Money’s Tim Collins looks for a bounce even in the middle of a longer term slide. Investment bankers like to talk about the movie “Jiro Dreams of Sushi.” The patter goes like this: The Read more…
The infighting raises governance questions surrounding NFT communities, especially what happens when founders fail to deliver on their promises. A flock of digital penguin avatars or “pengus” part of the popular non-fungible token community Pudgy Read more…
Bank of America settled a class action lawsuit last year over illegal overdraft fees. Bank of America (BAC) – Get Bank of America Corp Report is following some of its other banking peers down a more Read more…
Tech stocks are under pressure and Nvidia is getting hammered. That has the bulls looking for opportunity. The action in Nvidia (NVDA) – Get NVIDIA Corporation Report hasn’t been great lately, but that’s not too surprising Read more…
Tilray has been purchasing breweries and distilleries as it waits for federal legalization before introducing THC-infused beverages. Tilray (TLRY) – Get Tilray, Inc. Report and Anheuser-Busch InBev BUD recently ended their partnership, but the Canadian cannabis company’s push for THC Read more…
The agreement includes the option for the U.S. to buy additional doses in the second quarter, the companies say. GlaxoSmithKline (GSK) – Get GlaxoSmithKline Plc Report and its partner Vir Biotechnology (VIR) – Get Vir Biotechnology, Read more…